|
Time spent awaiting transplantation
|
Wait
|
1 month, 2 years, and 10 years.
|
Indirect utility of each 1 year reduction in transplant recipient waiting time.
|
|
Tissue type matching.
|
Tiss
|
Non-favourable match: 86% average kidney survival rate post-transplant.
|
Indirect utility of prioritizing people for each 1% improvement in kidney survival.
|
| | |
Favourable match: 89% average kidney survival rate post-transplant.
| |
| | |
Perfect match: 90% average kidney survival rate post-transplant.
| |
|
How many child or adult dependents recipients have
|
Dep
|
None, 1, or 4 dependents.
|
Indirect utility of each additional dependent.
|
|
Recipient age
|
Age
|
20 years, 45 years, and 65 years
|
Indirect utility for each 1 year reduction in recipient age.
|
|
Diseases predominantly affecting life expectancy
|
dis1
|
No disease affecting life expectancy (other than Kidney disease) vs. moderate disease (uncontrolled hypertension or obesity) & Kidney disease.
|
Indirect utility of having no rather than moderate disease predominantly affecting life expectancy.
|
| |
dis2
|
Moderate disease (uncontrolled hypertension or obesity) affecting life expectancy vs. severe disease (heart attack, stroke, or diabetes with complications).
|
Indirect utility of having moderate disease rather than severe disease predominantly affecting life expectancy.
|
|
Diseases predominantly affecting quality of life
|
ill1
|
No disease affecting quality of life (other than Kidney disease) vs. moderate disease (mild asthma).
|
Indirect utility of having no disease rather than a moderate disease predominantly affecting quality of life.
|
| |
ill2
|
Moderate disease (mild asthma) affecting quality of life vs. severe disease (severe arthritis).
|
Indirect utility of having a moderate disease rather than a severe disease predominantly affecting quality of life.
|
